CARM – carisma therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its price target lowered by analysts at D. Boral Capital from $12.00 to $1.00. They now have a "buy" rating on the stock.
Carisma Therapeutics Provides Corporate Updates [Yahoo! Finance]
Carisma Therapeutics Provides Corporate Updates
Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Form S-8 Carisma Therapeutics
Form 10-K Carisma Therapeutics For: Dec 31
Form 4 Carisma Therapeutics For: Jan 28 Filed by: Klichinsky Michael
Form 4 Carisma Therapeutics For: Jan 28 Filed by: Kelly Steven
Form 8-K Carisma Therapeutics For: Jan 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.